Skip to content

A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection

A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection - MOVI STUDY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014668
Enrollment
100
Registered
2014-08-15
Start date
2014-08-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumor

Interventions

Moviprep 1.5L ~ 2L Muben 3L ~ 4L

Sponsors

National Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent colorectal endoscopic submucosal dissection (ESD) at National Cancer Center Hospital. 1. Indication for colorectal ESD 2. Irrespective of number of the lesion 3. Age from 20 years old to 75 years old 4. Performance status 0, 1, 2 5. Patients who has written informed consent for this study

Exclusion criteria

Exclusion criteria: 1. Patients having risk of perforation, obstruction and suspicious of ileum. 2. Toxic megacolon 3. Allergy for Moviprep and Muben 4. Dehydration 5. Mental disease 6. Without written informed consent 7. Angina pectoris and/or past history of myocardial infarction within 6 months. 8. Active inflammatory bowel diseases 9. Past history of convulsive attack 10. Serum creatinine level ≥1.3 mg/dL 11. Others (depends on the chief physician)

Design outcomes

Primary

MeasureTime frame
Preparation time

Secondary

MeasureTime frame
Boston Bowel Preparation Scale score, acceptability, taste, frequencies of stool, total volume of the prep, complication rate.

Countries

Japan

Contacts

Public ContactMasayoshi Yamada

National Cancer Center Hospital Endoscopy Division

masyamad@ncc.go.jp+81-3-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026